Skip to Main Content

Paper Details

Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma.
Br J Cancer
7
2022
ALL, EWS, Ewing sarcoma, HR-NB, Ig, MRD, RNA, T cell receptor, TCR, WGS, acute lymphoblastic leukaemia, children, high-risk neuroblastoma, immunoglobulin, immunoglobulin (Ig) and T cell receptor (TCR) gene recombinations, leukaemic, leukaemic clones, methylated DNA, microRNA, mononuclear cells, neuroblastoma, patient, relapsed cancer, solid tumour, solid tumours, tumour, tumour cell, tumour-specific messenger RNA, tumours
Author NameAffiliation
Chelsea MayohChildren's Cancer Institute, Lowy Cancer Research Centre
Chelsea Mayoh
Vanessa TyrrellChildren's Cancer Institute, Lowy Cancer Research Centre
Vanessa Tyrrell
Vanessa TyrrellChildren's Cancer Institute, Lowy Cancer Research Centre
Vanessa Tyrrell
Glenn M MarshallChildren's Cancer Institute, Lowy Cancer Research Centre
Glenn M Marshall
Glenn M MarshallKids Cancer Centre, Sydney Children's Hospital
Mark J CowleyChildren's Cancer Institute, Lowy Cancer Research Centre
Mark J Cowley
Paul G EkertChildren's Cancer Institute, Lowy Cancer Research Centre
Paul G EkertPeter MacCallum Cancer Centre
Paul G EkertMurdoch Children's Research Institute, Royal Children's Hospital
Paul G Ekert
Michelle HaberChildren's Cancer Institute, Lowy Cancer Research Centre
Michelle Haber
Michelle J HendersonChildren's Cancer Institute, Lowy Cancer Research Centre
Michelle J Henderson
Jamie I FletcherChildren's Cancer Institute, Lowy Cancer Research Centre
Jamie I Fletcher
  • 1 - 21

Datasets

Release 1.2